Skip to main content

Retail Clinics

  • Sagent's generic Imitrex receives regulatory approval

    SCHAUMBURG, Ill. The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals for treating migraine attacks, Sagent said Monday.

     

    The FDA approved Sagent’s sumatriptan succinate injection in the 6 mg per 0.5 milliliter strength. The drug is used to treat acute migraine attacks and cluster headache episodes.

     

     

    Sumatriptan is a generic version of GlaxoSmithKline’s Imitrex. Injectable sumatriptan had $22 million in sales in 2009, according to IMS Health.

  • Study: Two therapies may slow diabetic retinopathy in Type 2 diabetes

    WINSTON-SALEM, N.C. In high-risk adults with Type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

  • NACDS urges FDA to move carefully in risk management rules for opioids

    ROCKVILLE, Md. Note to the Food and Drug Administration from the chain pharmacy industry: when it comes to beefing up oversight and regulation of some high-risk medications, slow and steady is the best approach.

  • Mylan markets generic Solodyn ER

    PITTSBURGH Mylan has launched a generic treatment for acne, the company said Thursday.

    Mylan announced the launch of minocycline hydrochloride extended-release tablets in the 45 mg, 90 mg and 135-mg strengths. The drug is a generic version of Solodyn ER, made by Medicis Pharmaceuticals Corp.

     

    Minocycline ER had sales of around $496 million during the 12-month period ended in March, according to IMS Health.

     

  • Beacon Community program seeks to curb diabetes across country

    WASHINGTON Vice President Joe Biden and the Department of Health and Human Services secretary Kathleen Sebelius have announced a pilot program designed to curb diabetes in 15 selected U.S. cities with the help of health-information technology.

  • Sandoz first to receive FDA approval for Lovenox generic

    SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

     

    The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

     

     

  • Pharmacist-patient relationships improve health, lower costs of care, UNC-Kerr study reveals

    RALEIGH, N.C. A healthy relationship with a community pharmacist can improve health outcomes for patients and save money, a new collaborative study from North Carolina-based Kerr Drug and the University of North Carolina revealed.

    Those benefits stem from direct interventions in patient therapy by pharmacists, coupled with a coordinated approach to the patient’s treatment regimen by his or her pharmacist and doctor, according to Kerr.

  • Nestle teams up with Cleveland Clinic for collaborative study

    GLENDALE, Calif. Nestle announced Thursday its donation to Cleveland Clinic's Lerner Research Institute to fund a collaborative study focused on examining the effects of a diet rich in whole grains on body composition and energy metabolism.

X
This ad will auto-close in 10 seconds